Prophylactic use of granulocyte colony-stimulating factor after induction chemotherapy in patients with newly diagnosed acute myeloid leukemia may increase the complete remission rate: a meta-analysis of five randomised controlled trials.
Wang
Jing
J
Department of Hematology, the Affiliated DrumTower Hospital of Nanjing University Medical School, Nanjing, PR China.
Zhan
Ping
P
Ouyang
Jian
J
Chen
Bing
B
Zhou
Rongfu
R
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use*; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D016017:Odds Ratio; D011292:Premedication; D016032:Randomized Controlled Trials as Topic; D012074:Remission Induction / Q000379:methods; D018401:Sample Size
D016179:Granulocyte Colony-Stimulating Factor